Filing Details
- Accession Number:
- 0001209191-21-061090
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-19 21:09:17
- Reporting Period:
- 2021-10-18
- Accepted Time:
- 2021-10-19 21:09:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1563880 | Trevi Therapeutics Inc. | TRVI | Pharmaceutical Preparations (2834) | 450834299 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1694560 | New Enterprise Associates 16, L.p. | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No | |
1712881 | Nea Partners 16, L.p. | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No | |
1712882 | Nea 16 Gp, Llc | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-10-18 | 1,851,852 | $0.00 | 7,789,850 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | 3.5-Year Common Stock Warrant | Acquisiton | 2021-10-18 | 1,851,852 | $0.00 | 1,851,852 | $1.37 |
Common Stock | 7-Year Common Stock Warrant | Acquisiton | 2021-10-18 | 1,851,852 | $0.00 | 1,851,852 | $1.37 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,851,852 | 2021-10-18 | 2025-04-18 | No | 4 | P | Direct |
1,851,852 | 2021-10-18 | 2028-10-18 | No | 4 | P | Direct |
Footnotes
- Represents securities acquired pursuant to a Securities Purchase Agreement (the "SPA"), dated October 15, 2021, by and between the Issuer and New Enterprise Associates 16, L.P. ("NEA 16"), with a closing on October 18, 2021. Pursuant to the terms of the SPA, NEA 16 purchased common units for $1.62 per common unit. Each common unit consisted of one share of the Issuer's common stock, one 3.5 year common stock warrant, and one 7-year common stock warrant.
- The securities are directly held by NEA 16, and indirectly held by NEA Partners 16, L.P. ("NEA Partners"), the sole general partner of NEA 16, NEA 16 GP, LLC ("NEA 16 GP"), the sole general partner of NEA Partners 16, and the individual managers of NEA 16 GP (NEA Partners 16, NEA 16 GP and the individual managers of NEA 16 GP (collectively, the "Managers"), together, the "Indirect Reporting Persons"). The Managers of NEA 16 GP are Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad Makhzoumi, Scott D. Sandell, Peter W. Sonsini and Paul Walker. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Indirect Reporting Persons have no pecuniary interest.